An imbalance in the gut microbiota's catalytic functions can contribute to various diseases, including inflammatory bowel disease (IBD), obesity, and metabolic syndrome. For example, a reduced capacity to produce SCFAs due to a lack of fiber-fermenting bacteria can lead to chronic inflammation and associated health issues. Understanding the catalytic roles of different microbial species can aid in developing targeted therapies for these conditions.
